Centers of Excellence in Genomic Science (CEGS)
Funding Amount
$5,000,000 total
Deadline
Forecast — dates not yet posted
Number of Awards
2
Grant Type
Federal
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Nonprofits (501(c)(3))
- Public colleges & universities
- Private colleges & universities
- Nonprofits without 501(c)(3) status
- Tribal organizations
- City & township governments
- Special district governments
- School districts
Geography
- Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Overview
The National Human Genome Research Institute (NHGRI) intends to promote an initiative by publishing a Notice of Funding Opportunity (NOFO) to solicit applications for the Centers of Excellence in Genomic Science (CEGS) program. The purpose of the CEGS program is to bring together interdisciplinary teams of investigators to form tightly focused, well-integrated projects that address challenging biomedical questions from a genomics perspective. CEGS are expected to develop highly innovative novel concepts, methods, approaches, tools, and technologies to address these questions and achieve a transformative advance not likely developed by standard R01s or other projects over the same timeframe. Importantly, each CEGS will address a critical issue in genomic science, genomic medicine, computational genomics, or an issue that cuts across more than one of these areas. Given these goals, each center is required to have outstanding scientific plans and management strategies that balance a high level of risk with the potential for high payoff. Additional goals of the CEGS program include broadening the pool of researchers able to work in or use genomics, and dissemination of CEGS developed methods and tools to the broader research community. In February 2024 a mixed-methods evaluation ( see evaluation report ) was completed to assess the outcomes of this flagship NHGRI program. The evaluation highlighted several strengths such as the high-risk, high-reward nature of the CEGS funding mechanism, a focus on technology development linked to biological questions, and the funding of several breakthrough resources and approaches that have surpassed genomics to stimulate many research areas. Suggestions for improvements, such as widening the focus and increasing outreach opportunities, will be addressed in this renewal.
Details
- Agency: National Institutes of Health
- Department: Department of Health and Human Services
- Opportunity #: PAR-26-036
- Total Funding: $5,000,000
- Expected Awards: 2
- Instrument: cooperative_agreement
Eligibility
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Focus Areas & Funding Uses
Fields of Work
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)
National Institutes of Health
Amount
Up to $1M
Deadline
October 9, 2026
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 9, 2026
Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$650,000 total
Deadline
October 9, 2026
Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (R01 Clinical Trial Required)
National Institutes of Health
Amount
$5,000,000 total
Deadline
October 11, 2026
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 14, 2026
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 14, 2026
Ready to apply for Centers of Excellence in Genomic Science (CEGS)?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Centers of Excellence in Genomic Science (CEGS). Now let's win it.